Prognostic value of MMP-2, -9 and TMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas

Pathology Research and Practice

Volumn 198, Issue 8, 2002, Pages 509-515

  Ondruschka, Constanze ^a   Buhtz, Peter ^a   Motsch, Christiane ^a   Freigang, Bernd ^a   Schneider Stock, Regine ^a   Roessner, Albert ^a   Boltze, Carsten ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

MMP; Prognosis; Squamous cell carcinoma; TIMP

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME RELEASE; EXTRACELLULAR MATRIX; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TISSUE DISTRIBUTION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0036388569     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/S0344-0338(04)70292-7     Document Type: Article

References (26)

1. Afzal S, Lalani E, Foulkes W et al. (1996) Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Lab Invest 74: 406-421
2. Azzam HS, Arand G, Lippman ME, Thompson EW (1993) Association from MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 activation. J Natl Cancer Inst 85:1758-1764
3. Bando EY, Yonemura Y, Endou Y et al. (1998) Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep 5:1483-1488
4. Brown PD (1998) Matrix metalloproteinase inhibitors. Breast Cancer Res Treat 52: 125-136
5. Bryne M, Jenssen N, Boysen M (1995) Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virch Arch 427: 277-281
6. Cazorla M, Hernandez L, Nadal A et al. (1998) Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 186: 144-150
7. Davidson B, Goldberg I, Kopolovic J et al. (1999) MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - A clinicopathologic study using immunohistochemistry and mRNA in situ hybridisation. Gyn Oncol 73: 372-382
8. Du B, Wang P, Guo X, Du B (1999) Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma. Pathol Oncol Res 5: 214-217
9. Hall SF, Groome PA, Rothwell D, Dixon P (1999) Using TNM staging to predict survival in patients with squamous cell carcinoma of head and neck. Head Neck 21: 30-38
10. Howaldt HP, Fenz M, Pitz H (1994) Results from DOSAK observational studies. Cancer Res 134: 173-182
11. Ikebe T, Shinohara M, Takeuchi H et al. (1999) Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Met 17: 315-323
12. Kleiner D, Stetler-Stevenson WG (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43: 42-51
13. Levi F, Lucchini F, La Vecchia C, Negri E (1999) Trends in mortality from cancer in the European Union, 1955-94. Lancet 354: 742-743
14. Mann EA, Hibbs MS, Spiro JD et al. (1995) Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: The role of tumor necrosis factor-alpha. Ann Otol Rhinol Laryngol 104: 203-209
15. Miyajima Y, Nakano R, Morimatsu M (1995) Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridisation. Ann Otol Rhinol Laryngol 104: 678-685
16. Muller D, Breathnach R, Engelmann A et al. (1991) Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumors. Int J Cancer 48: 550-556
17. Ohashi K, Nemoto T, Nakamura K, Nemori R (2000) Increased expression of matrix metalloproteinase-7 and -9 and membrane type-1 matrix metalloproteinase in oesophageal squamous cell carcinoma. Cancer 88: 2201-2209
18. Okumura K, Konishi A, Tanaka M, Kanazawa M, Kogawa K, Niitsu Y (1996) Establishment of high- and low-invasion clones derived for a human tongue squamous cell carcinoma cell line SAS. J Cancer Res Clin Oncol 1996; 122: 243-248
19. Remmele W, Hildebrand U, Hienz H et al. (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors and Barr bodies in human breast cancer. Virch Arch 409: 127-147
20. Sarioglu S, Ozer E, Kirimca F, Sis B, Pabuccuoglu U (2001) Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol Res Pract 197: 483-486
21. Schwartz G (1996) Invasion and metastasis in gastric cancer: In vitro and in vivo models with clinical correlations. Oncology 23: 316-324
22. Sier CF, Kubben FJ, Ganesh S et al. (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to overall survival of patients with gastric carcinoma. Br J Cancer 74: 413-417
23. Sutinen M, Kainulainen T, Hurskainen T et al. (1998) Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 77: 2239-2245
24. Talvensaari-Mattila A, Paakko P, Hoyhtya M, Blanco-Sequeiros G, Turpeenniemi-Hujanen T (1998) Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma. Cancer 83: 1153-1162
25. Valente P, Fassina G, Melchiori A et al. (1998) TIMP-2 Overexpression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 75: 246-253
26. Visscher W, Höyhtya M, Ottosen SK et al. (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59: